CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.

The DNA mismatch repair (MMR) system plays an important role in mediating a G2-M checkpoint arrest and subsequent cell death following treatment with a variety of chemotherapeutic agents. In this study, using 6-thioguanine (6-TG) as a mismatch-inducing drug, we examine the role of ataxia telangiectasia mutated (ATM)/CHK2 and ATM and Rad-3 related (ATR)/CHK1 signaling pathways in MMR-mediated cell cycle responses in MMR-proficient human colorectal cancer RKO cells. We show that, in response to 6-TG (3 micromol/L x 24 hours), activating phosphorylation of CHK1 at Ser317 [CHK1(pS317)] and CHK2 at Thr68 [CHK2(pT68)] are induced differentially during a prolonged course (up to 6 days) of MMR-mediated cell cycle arrests following 6-TG treatment, with CHK1(pS317) being induced within 1 day and CHK2(pT68) being induced later. Using chemical inhibitors and small interfering RNA of the signaling kinases, we show that a MMR-mediated 6-TG-induced G2 arrest is ATR/CHK1 dependent but ATM/CHK2 independent and that ATR/CHK1 signaling is responsible for both initiation and maintenance of the G2 arrest. However, CHK2(pT68) seems to be involved in a subsequent tetraploid G1 arrest, which blocks cells that escape from the G2-M checkpoint following 6-TG treatment. Furthermore, we show that CHK2 is hyperphosphorylated at later times following 6-TG treatment and the phosphorylation of CHK2 seems to be ATM independent but up-regulated when ATR or CHK1 is reduced. Thus, our data suggest that CHK1(pS317) is involved in a MMR-mediated 6-TG-induced G2 arrest, whereas CHK2(pT68) seems to be involved in a subsequent tetraploid G1-S checkpoint. The two signaling kinases seem to work cooperatively to ensure that 6-TG damaged cells arrest at these cell cycle checkpoints.

[1]  P. Karran,et al.  DNA damage tolerance, mismatch repair and genome instability , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  P. Peltomäki.  Role of DNA mismatch repair defects in the pathogenesis of human cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Baltimore,et al.  Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. , 2003, Genes & development.

[4]  K. Vermeulen,et al.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer , 2003, Cell proliferation.

[5]  S. Aebi,et al.  The role of DNA mismatch repair in drug resistance. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  J. Griffith,et al.  Preferential binding of ATR protein to UV-damaged DNA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Sarkaria,et al.  Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. , 1999, Cancer research.

[8]  I. Jacobs,et al.  Methylation of hMLH1 in a population-based series of endometrial carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  M. Kirsch‐Volders,et al.  p53-independent apoptosis and p53-dependent block of DNA rereplication following mitotic spindle inhibition in human cells. , 1999, Experimental cell research.

[10]  M. Kastan,et al.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.

[11]  E. Tokunaga,et al.  Differential growth inhibition by 5-fluorouracil in human colorectal carcinoma cell lines. , 2000, European journal of cancer.

[12]  A. Kumagai,et al.  Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. , 2000, Genes & development.

[13]  M. Gatei,et al.  Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells , 1999, Oncogene.

[14]  Y Taya,et al.  A role for ATR in the DNA damage-induced phosphorylation of p53. , 1999, Genes & development.

[15]  K. Cimprich,et al.  Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint , 2000, Current Biology.

[16]  J. Jiricny,et al.  Methylation‐induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1 , 2003, The EMBO journal.

[17]  T. Kunkel,et al.  DNA-replication fidelity, mismatch repair and genome instability in cancer cells. , 1996, European journal of biochemistry.

[18]  Qinguo Zheng,et al.  Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of Thioguanine , 1996, Science.

[19]  R. Abraham.  Cell cycle checkpoint signaling through the ATM and ATR kinases. , 2001, Genes & development.

[20]  T. Waters,et al.  Cytotoxic mechanism of 6-thioguanine: hMutSalpha, the human mismatch binding heterodimer, binds to DNA containing S6-methylthioguanine. , 1997, Biochemistry.

[21]  A. Giaccia,et al.  ATR/ATM Targets Are Phosphorylated by ATR in Response to Hypoxia and ATM in Response to Reoxygenation* , 2003, The Journal of Biological Chemistry.

[22]  S. Elledge,et al.  Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. , 2002, Genes & development.

[23]  Z. Darżynkiewicz,et al.  Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. , 1998, Cytometry.

[24]  T. Kinsella,et al.  DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[25]  K. Cimprich,et al.  A requirement for replication in activation of the ATR-dependent DNA damage checkpoint. , 2002, Genes & development.

[26]  M. Meyers,et al.  Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. , 2001, Cancer research.

[27]  J. Herman,et al.  Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. , 1999, Cancer research.

[28]  J. Jiricny,et al.  Mismatch repair defects in cancer. , 2000, Current opinion in genetics & development.

[29]  P. Karran,et al.  DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage. , 1994, Biochemistry.

[30]  Xiang Wang,et al.  An Overactivated ATR/CHK1 Pathway Is Responsible for the Prolonged G2 Accumulation in Irradiated AT Cells* , 2003, Journal of Biological Chemistry.

[31]  S. Elledge,et al.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. , 2000, Genes & development.

[32]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[33]  Jun Qin,et al.  ATR and ATRIP: Partners in Checkpoint Signaling , 2001, Science.

[34]  K. Kohn,et al.  UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. , 2002, Cancer research.

[35]  W. Cliby,et al.  S Phase and G2 Arrests Induced by Topoisomerase I Poisons Are Dependent on ATR Kinase Function* , 2002, The Journal of Biological Chemistry.

[36]  H. Yamamoto,et al.  Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. , 1998, Cancer research.

[37]  A. Hall,et al.  Mismatch repair defects as a cause of resistance to cytotoxic drugs , 2001, Expert review of anticancer therapy.

[38]  A. Giaccia,et al.  Hypoxia Links ATR and p53 through Replication Arrest , 2002, Molecular and Cellular Biology.

[39]  G. Aquilina,et al.  Mismatch repair in correction of replication errors and processing of DNA damage , 2001, Journal of cellular physiology.

[40]  N. Gueven,et al.  ATP Activates Ataxia-Telangiectasia Mutated (ATM) in Vitro , 2003, The Journal of Biological Chemistry.

[41]  Y. Shiloh.  ATM and related protein kinases: safeguarding genome integrity , 2003, Nature Reviews Cancer.

[42]  Guo-Min Li,et al.  The role of mismatch repair in DNA damage-induced apoptosis. , 1999, Oncology research.

[43]  L. Kasturi,et al.  Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Modrich,et al.  Mismatch repair in replication fidelity, genetic recombination, and cancer biology. , 1996, Annual review of biochemistry.

[45]  G. Marsischky,et al.  Eukaryotic DNA mismatch repair. , 1999, Current opinion in genetics & development.